Clinic lung function during treatment
| Fluticasone propionate + salmeterol (n = 139) | Fluticasone propionate double dose (n = 135) | Adjusted3-150 difference (SE) between groups | 95 % confidence interval | p value | |||||
|---|---|---|---|---|---|---|---|---|---|
| FEV1 (l) | Visit | 3 | 2.38 (0.75) | 2.39 (0.75) | |||||
| 4 | 2.53 (0.77) | 2.45 (0.83) | 0.09 (0.044) | 0.01 to 0.18 | 0.04 | ||||
| 5 | 2.47 (0.76) | 2.48 (0.89) | 0.05 (0.041) | 0.02 to 0.14 | 0.18 | ||||
| FVC (l) | Visit | 3 | 3.72 (1.06) | 3.71 (1.14) | |||||
| 4 | 3.85 (1.08) | 3.72 (1.25) | 0.13 (0.053) | 0.03 to 0.23 | 0.02 | ||||
| 5 | 3.73 (1.10) | 3.75 (1.21) | 0.02 (0.051) | −0.08 to 0.12 | 0.64 | ||||
| PEF (l/min) | Visit | 3 | 367 (114) | 365 (117) | |||||
| 4 | 391 (111) | 367 (115) | 17.6 (7.4) | 3.14 to 32.0 | 0.02 | ||||
| 5 | 386 (122) | 384 (120) | 6.6 (8.2) | −9.45 to 22.7 | 0.42 | ||||
For abbreviations see table 2.
↵3-150 Adjusted for the baseline measurement at visit 2 (ANCOVA).